Genmab A/S (GNMSF)
Genmab Market Cap : 31.33B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 31.33B |
| November 12, 2026 | 31.33B |
| November 11, 2026 | 33.27B |
| November 10, 2026 | 33.27B |
| November 09, 2026 | 33.58B |
| November 06, 2026 | 32.35B |
| November 05, 2026 | 33.08B |
| November 04, 2026 | 33.58B |
| November 03, 2026 | 34.67B |
| November 02, 2026 | 33.66B |
| October 30, 2026 | 33.66B |
| October 29, 2026 | 33.15B |
| October 28, 2026 | 34.63B |
| October 27, 2026 | 26.21B |
| October 26, 2026 | 26.72B |
| October 23, 2026 | 26.72B |
| October 22, 2026 | 23.19B |
| October 21, 2026 | 23.19B |
| October 20, 2026 | 23.19B |
| October 19, 2026 | 22.57B |
| October 16, 2026 | 21.91B |
| October 15, 2026 | 21.91B |
| October 14, 2026 | 21.91B |
| October 13, 2026 | 21.91B |
| October 12, 2026 | 21.91B |
| Date | Value |
|---|---|
| October 09, 2026 | 21.91B |
| October 08, 2026 | 22.57B |
| October 07, 2026 | 22.57B |
| October 06, 2026 | 22.45B |
| October 05, 2026 | 23.70B |
| October 02, 2026 | 21.19B |
| October 01, 2026 | 21.19B |
| September 30, 2026 | 21.19B |
| September 29, 2026 | 21.19B |
| September 28, 2026 | 21.19B |
| September 25, 2026 | 21.07B |
| September 24, 2026 | 20.70B |
| September 23, 2026 | 20.22B |
| September 22, 2026 | 20.90B |
| September 21, 2026 | 20.48B |
| September 18, 2026 | 20.48B |
| September 17, 2026 | 20.48B |
| September 16, 2026 | 20.36B |
| September 15, 2026 | 20.24B |
| September 14, 2026 | 19.66B |
| September 11, 2026 | 19.66B |
| September 10, 2026 | 19.66B |
| September 09, 2026 | 19.66B |
| September 08, 2026 | 19.66B |
| September 04, 2026 | 19.66B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Ascendis Pharma A/S | 17.84B |
| Zealand Pharma A/S | 2.478B |
| Bavarian Nordic A/S | 2.662B |
| Evaxion AS | 23.77M |
| ACADIA Pharmaceuticals, Inc. | 3.223B |
Market Cap Related Metrics
| PE Ratio | 43.62 |
| PS Ratio | 7.568 |
| Price to Book Value | 4.947 |
| Price to Free Cash Flow | 38.99 |
| Price | 509.50 |
| Earnings Yield | 2.29% |
| Operating PE Ratio | 24.70 |
| Normalized PE Ratio | 34.96 |